CBS 2019
CBSMD教育中心
中 文

Scientific Library

Abstract

Recommended Article

Thirty-Day Outcomes Following Transfemoral Transseptal Transcatheter Mitral Valve Replacement: Intrepid TMVR Early Feasibility Study Results 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines Expansion or contraction of stenting in coronary artery disease? From Focal Lipid Storage to Systemic Inflammation Relation between baseline plaque features and subsequent coronary artery remodeling determined by optical coherence tomography and intravascular ultrasound Diagnostic accuracy of cardiac positron emission tomography versus single photon emission computed tomography for coronary artery disease: a bivariate meta-analysis Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction Novel percutaneous interventional therapies in heart failure with preserved ejection fraction: an integrative review

Clinical TrialNov 06, 2021.

JOURNAL:J Am Coll Cardiol Intv. Article Link

Thirty-Day Outcomes Following Transfemoral Transseptal Transcatheter Mitral Valve Replacement: Intrepid TMVR Early Feasibility Study Results

F Zahr , HK Song , SM Chadderdon et al. Keywords: TMVR; early feasibility study; 30-day outcome

Full Text PDF